Dr. David Goldsteen, CEO of VigiLanz, which provides clinical surveillance for hospitals and health systems to improve safety and mitigate risk discusses key survey findings from their third annual survey, revealing hospitals’ top patient priorities, benchmarked over time. He talks about steps health leaders can take to address patient and staff safety – from getting ahead of potential infections and outbreaks, medication errors and antibiotic overuse, to safety events, such as falling. As COVID numbers continue to decline in most markets and hospital capacities are normalizing, now is the time to reevaluate current processes and procedures that can help mitigate avoidable safety issues.
Dr. Neal Kassell, founder and chairman of the Focused Ultrasound Foundation, discusses focused ultrasound, a revolutionary, non-invasive, highly disruptive technology approved in the United States to treat essential tremor, tremor-dominant Parkinson’s disease, uterine fibroids, pain from bone metastases, and prostate cancer. The technology is in various stages of research and development around the world for more than 100 diseases and conditions, including ALS, Alzheimer’s, hypertension, and tumors of the brain, liver, breast, and pancreas. He talks about how this therapy is poised to impact the way we treat some of our most elusive diseases.
Dr. Daniel Catenacci, MD, director of the Gastrointestinal Oncology Program at the University of Chicago, discusses data from Astellas’ Phase 2 FAST study, which evaluated zolbetuximab, an investigational first-in-class anti-CLDN18.2 monoclonal antibody, in combination with first-line epirubicin, oxaliplatin, and capecitabine (EOX) in patients with advanced gastric cancer. He discusses efficacy and safety results, as well as patient-reported outcomes (PROs) data from the study. He also shares background on the overall gastric cancer landscape and unmet needs of patients facing this disease.
Returning guest, Dr. William Flood, Chief Medical Officer for Eviti at Nanthealth discusses the newly launched Eviti Connect for autoimmune diseases. Used by over 6,900 oncology practices nationwide with its library of over 4,400 evidence-based treatment regimens, Eviti Connect is now able to serve as a go-to resource in the autoimmune space on top of its proven expertise in oncology. The Eviti library now covers the most prevalent autoimmune diseases, such as inflammatory bowel disease, rheumatoid arthritis, plaque psoriasis and multiple sclerosis. He talks about the company’s plans for this expansion and why they chose these two important areas of focus (cancer care and now autoimmune diseases).
Heart disease is the leading cause of death for women in the United States, yet only about half of women recognize that heart disease is their number one killer. Returning guest, Dr. Suzanne Steinbaum, attending cardiologist in NYC, and founder and president of SRSHeart, discusses managing high cholesterol with a busy schedule, how statin therapy may be a critical part of achieving cholesterol goals and that there are several statins available but not all statins are the same.
Christoph Dankert discusses Carrum Health, the first digital health company directly connecting self-insured employers with the best providers in the nation, like Cleveland Clinic, John Hopkins and Mayo Clinic, to improve health outcomes, lower costs, and enhance the patient experience. He talks about the results of a recent peer-reviewed Rand Corp. study showing the vast difference in cost between fee-for-service and bundled payment surgery models, the emerging role of Centers of Excellence and key trends in value-based care.
Dr. Jenice Baker, Assistant Medical Director of the Emergency Department and Attending Physician at Our Lady of Lourdes Hospital in Camden NJ, discusses the “No Time to Wait” campaign and educates viewers about deep vein thrombosis (DVT) and pulmonary embolism (PE) symptoms and why it’s critical for those experiencing symptoms that could be due to DVT or PE to consult a healthcare provider.
Heart failure (HF) accounts for nearly 2 hospitalizations every minute in the U.S. Beth Davidson, a HF nurse practitioner in Nashville, TN, and President of the American Association of HF Nurses discusses HF, symptoms, the seriousness of HF hospitalization, and treatment and lifestyle tips that may help patients or a loved one manage the condition. She is joined by Kim , who at 32 was shocked to be diagnosed with HF. She is now 53 and shares her story and how she is successfully managing her HF today.
May is bladder cancer awareness month and Dr. Alicia Morgans, board-certified medical oncology physician at the Robert H. Lurie Comprehensive Cancer Center discusses the rise in bladder cancer cases, the most important questions for patients to ask their doctor, and explains why these tough conversations can be so important. She also talks about the new educational campaign “Let’s Target the Tough Stuff” to help people understand the warning signs and symptoms of the disease.
Hospice patients with dementia are up to four times more likely to be disenrolled before death than patients without dementia (PWD). Additionally, PWD who are also racial minorities may receive lower quality of care while in hospice. Dr. Lauren Hunt, PhD, RN, FNP of UCSF, Department of Physiological Nursing, University of California San Francisco discusses these findings that were part of “Risk Factors for Disenrollment from Hospice in Persons with Dementia: A National Cohort Study”, that was presented at the 2021 American Geriatrics Society General Meeting.